Another proposed mechanisms is induction of the glucuronidation in acute myeloid leukemia (AML), where GLI1 is sufficient to drive UGT1A-dependent glucuronidation of ribavirin and cytarabine, leading to resistance [300]. The gene discussed is UGT1A1; the disease is acute myeloid leukemia.